Research output per year
Research output per year
Equipments Details
Description
The Australian Translational Medicinal Chemistry Facility (ATMCF) is a purpose-designed, outward-facing, collaborative facility translating new discoveries in disease biology into suitably targeted therapeutics for clinical development.
ATMCF will partner with suitable researchers in disease biology to efficiently and effectively address the multifaceted requirements of drug-discovery.
By working to a suitably defined target product profile (TPP) that addresses an unmet medical need, the complimentary capabilities of the partner and the ATMCF and its other ancillary partners will be combined to achieve a fully integrated drug discovery platform
ATMCF will partner with suitable researchers in disease biology to efficiently and effectively address the multifaceted requirements of drug-discovery.
By working to a suitably defined target product profile (TPP) that addresses an unmet medical need, the complimentary capabilities of the partner and the ATMCF and its other ancillary partners will be combined to achieve a fully integrated drug discovery platform
Research output
- 7 Article
-
Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract
Pitcher, N. P., Harjani, J. R., Zhao, Y., Jin, J., Knight, D. R., Li, L., Putsathit, P., Riley, T. V., Carter, G. P. & Baell, J. B., Mar 2022, In: ACS Omega. 7, 8, p. 6737-6759 23 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access8 Citations (Scopus) -
MerTK activity is not necessary for the proliferation of glioblastoma stem cells
Hoque, M., Wai Wong, S., Recasens, A., Abbassi, R., Nguyen, N., Zhang, D., Stashko, M. A., Wang, X., Frye, S., Day, B. W., Baell, J. & Munoz, L., Apr 2021, In: Biochemical Pharmacology. 186, 18 p., 114437.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Structure-Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity
Varghese, S., Rahmani, R., Drew, D. R., Beeson, J. G., Baum, J., Smith, B. J. & Baell, J. B., 17 Feb 2021, In: ChemMedChem. 16, 4, p. 679-693 15 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus)
-
Discovery of New Antimalarials with a Novel Mechanism of Action and Irresistible Target
Giannangelo, C. (Primary Chief Investigator (PCI)), Dillon, A. (Chief Investigator (CI)), Shackleford, D. (Chief Investigator (CI)), Edstein, M. (Chief Investigator (CI)), Creek, D. (Associate Investigator (AI)), Charman, S. (Associate Investigator (AI)), Burrows, J. N. (Associate Investigator (AI)), Stupple, P. (Associate Investigator (AI)), Gilson, P. (Associate Investigator (AI)), Niles, J. (Associate Investigator (AI)), Delves, M. (Associate Investigator (AI)) & Wittlin, S. (Associate Investigator (AI))
1/01/25 → 31/12/27
Project: Research
-
Data Driven Discovery of New Catalysts for Asymmetric Synthesis
Priebbenow, D. (Primary Chief Investigator (PCI)) & Leitch, D. (Partner Investigator (PI))
Australian Research Council (ARC), University of Victoria (Canada)
29/05/24 → 28/05/27
Project: Research
-
MedChem Australia – catalysing value creation in drug discovery
Stupple, P. (Primary Chief Investigator (PCI)), Charman, S. (Chief Investigator (CI)), Lessene, G. (Chief Investigator (CI)), Kassiou, M. (Chief Investigator (CI)), Mitchell, J. (Chief Investigator (CI)) & Newman, S. (Chief Investigator (CI))
Therapeutic Innovation Australia Limited, Monash University, Walter and Eliza Hall Institute of Medical Research (WEHI), University of Sydney
30/06/23 → 6/12/28
Project: Research